PlenOptika, Inc

PlenOptika is a medical technology company specializing in portable vision care diagnostics. The company manufactures handheld autorefractors and keratometers based on wavefront aberrometry technology, with a primary focus on expanding access to refractive error measurement in clinical, retail, and mobile care settings. The flagship product line consists of QuickSee Free (handheld autorefractor) and QuickSee Free Pro (autorefractor with keratometry capability), both designed for optometrists, ophthalmologists, optical retailers, and mobile health programs. These devices employ a proprietary Wavefront Refraction Engine to deliver clinical-grade autorefraction measurements from a lightweight, handheld platform. The QuickSee Free Companion App provides advanced clinical analytics including wavefront aberrometry data, visual acuity simulations, Zernike coefficients, and generates printable patient reports with clinical recommendations. PlenOptika targets vision professionals in developed markets and global health organizations serving underserved populations in developing regions. The company has been recognized with multiple clinical and innovation awards, including the Silmo d'Or 2023, Prism Awards, and recognition from the American Academy of Ophthalmology. QuickSee Free has been selected for space flight research applications, including deployment on the Polaris Dawn mission, demonstrating the device's clinical reliability. The company emphasizes addressing the global burden of refractive error and myopia epidemic through innovative, portable diagnostic tools that overcome limitations of traditional fixed-location eye care delivery models.